// App-Quantinova.ai

243 : Expression of T-cell checkpoint ligands on circulating tumor cells is modulated following treatment of patients with an anti-tumor DNA vaccine

Researchers

Presenter

  • Brian T. Rekoske

Principal Investigators

  • Brian M. Olson

  • Douglas G. McNeel

Medical Centers

  • Univ. of Wisconsin-Madison, Madison, WI.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Programmed cell death protein 1

  • Programmed death-ligand 1

  • Cluster of differentiation 8A

  • Prostatic acid phosphatase

  • Epithelial Cell Adhesion Molecule

  • Human leukocyte antigen A2

Drug/Treatment

  • galectin-9

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved